Research / Clinical
Summary
|
|
Diseases/Research Topics
Bladder, Cancer, Cancer prevention and control, Complexed PSA, Epidemiology, Kidney, Prostate Cancer, Prostatectomy
Dr. Parsons research focuses on the epidemiology, prevention, and treatment of prostate cancer and prostate hyperplasia. He is particularly interested in clinical trials, outcomes research, and improving patient care through the application of evidence-based medicine. His previous research has included identification of free testosterone as a risk factor for prostate cancer, optimization of prostate cancer diagnosis utilizing prostate-specific antigen (PSA) isoforms, and descriptions of novel risk factors for prostate hyperplasia.
Dr. Parsons clinical practice focuses on the minimally-invasive treatment of urological malignancies, including prostate cancer, kidney cancer, and bladder cancer. He has special training and experience in performing a number of minimally-invasive laparoscopic and robotic surgical techniques. Using the new da Vinci robotic system at UCSD’s Thornton Hospital, Dr. Parsons performs robot-assisted prostatectomy to improve patient outcomes and speed recovery
Dr. Parsons is the principal investigator at UCSD for the Selenium and Vitamin E Prostate Cancer Prevention Trial (SELECT). He is also designing studies to prevent prostate cancer using diet and improving minimally-invasive surgical treatments of prostate cancer using evidence-based medicine
Update Summary via ONcLINE (password required)
Click here to request a
new or forgotten password
|
